Mithrl
Technology
Company overview
Mithrl is a biomedical AI platform that accelerates drug development research. The company describes itself as a Scientific Decision Engine. Its Mithrl-1 model is a biomedical world model built to identify novel drug targets, discover biomarkers, interpret results and decode drug mechanisms of action. Mithrl says its platform can accelerate R&D cycles by 32X on average.
Mithrl was co-founded by Vivek Adarsh, CEO, and Shara Balakrishnan, CTO. The company raised $20 million in Series A funding in September 2026.
- Industry
- Technology
- Headquarters
- United States